{"id":579,"date":"2018-07-19T08:24:26","date_gmt":"2018-07-19T06:24:26","guid":{"rendered":"https:\/\/fci.health\/startseite\/"},"modified":"2023-12-04T09:44:39","modified_gmt":"2023-12-04T08:44:39","slug":"startseite","status":"publish","type":"page","link":"https:\/\/fci.health\/en\/","title":{"rendered":"Homepage"},"content":{"rendered":"

[vc_row full_width=”stretch_row_content_no_spaces” dhsv_overflow=”vc-overflow-visible”][vc_column][dhsv_vc_header type=”video” video=”472″ video_mobile=”499″ texttop=”Einzigartige Umgebung” textbottom=”Wissensvermittlung an Patienten” elements=”%5B%7B%22texttop%22%3A%22Unique%20Environment%22%2C%22textbottom%22%3A%22Interdisciplinary%22%7D%2C%7B%22texttop%22%3A%22Molecular%20Mechanisms%22%2C%22textbottom%22%3A%22Precision%20Oncology%22%7D%2C%7B%22texttop%22%3A%22Translation%20and%20Reverse%20Translation%22%2C%22textbottom%22%3A%22Innovation%22%7D%2C%7B%22texttop%22%3A%22Exceptional%20Career%20Opportunities%22%2C%22textbottom%22%3A%22Spirit%20of%20collaboration%22%7D%2C%7B%22texttop%22%3A%22Team%20Culture%22%2C%22textbottom%22%3A%22Interdisciplinary%20Education%22%7D%2C%7B%22texttop%22%3A%22Shared%20Cutting%20Edge%20Resources%22%2C%22textbottom%22%3A%22Bottom-up%20Ideas%22%7D%5D”][\/vc_column][\/vc_row][vc_row dhsv_margin_top=”vc-margin-top-medium” dhsv_margin_bottom=”vc-margin-bottom-medium”][vc_column][dhsv_vc_anker type=”nav”][dhsv_vc_forschungsbereiche headtitle=”Research at FCI” elements=”%5B%7B%22line1%22%3A%22Clinical%20Translation%20Programs%22%2C%22line2%22%3A%22Strategic%20Core%20of%20FCI%22%2C%22text%22%3A%22Multidisciplinary%20teams%20consisting%20of%20clinicians%2C%20tumor%20biologists%2C%20biochemists%2C%20chemists%20and%20bioinformaticians%20work%20together%20in%20these%20interdisciplinary%20research%20projects.%20The%20teams%20rely%20on%20the%20technology%20platforms%20provided%20by%20the%20five%20research%20areas.%20%22%2C%22link%22%3A%22url%3Ahttps%253A%252F%252Ffci.health%252Fen%252Fresearch%252Fclinical-translation-programs%252F%7C%7C%7C%22%2C%22color%22%3A%22blue%22%7D%2C%7B%22line1%22%3A%22P1%22%2C%22line2%22%3A%22Proteomics%20%26%20Functional%20Genomics%22%2C%22text%22%3A%22The%20goal%20of%20Technology%20Platform%201%20is%20to%20find%20individual%20parameters%20that%20can%20improve%20the%20diagnosis%20of%20tumors%20or%20better%20predict%20the%20response%20to%20therapy.%20For%20example%2C%20the%20composition%20of%20all%20proteins%20in%20a%20cell%20can%20be%20qualitatively%20and%20quantitatively%20analyzed%20by%20means%20of%20mass%20spectrometry.%20The%20measured%20profile%20(%E2%80%9Cproteome%E2%80%9D)%20contains%20unique%20information%20%E2%80%93%20similar%20to%20a%20fingerprint%20%E2%80%93%20and%20by%20comparing%20tumor%20cells%20with%20healthy%20cells%20of%20the%20same%20patient%2C%20new%20prognostic%20and%20diagnostic%20criteria%20can%20be%20identified.%22%2C%22link%22%3A%22url%3Ahttps%253A%252F%252Ffci.health%252Fen%252Fresearch%252Fresearch-areas%252Ff1%252F%7C%7C%7C%22%2C%22color%22%3A%22gray%22%7D%2C%7B%22line1%22%3A%22P2%22%2C%22line2%22%3A%22Immuno-Oncology%22%2C%22text%22%3A%22Technology%20platform%202%20Immuno-Oncology%20uses%20the%20innovative%20cell%20type-specific%20gene%20transfer%20technologies%20available%20at%20FCI%20to%20develop%20new%20immunotherapeutic%20concepts.%20These%20include%20the%20genetic%20modification%20of%20T%20lymphocytes%20or%20natural%20killer%20cells%20(NKs)%20with%20chimeric%20antigen%20receptors%20(CARs)%20as%20well%20as%20the%20precise%20transfer%20of%20immunomodulatory%20agents%20into%20tumor%20tissue.%5CnThis%20is%20complemented%20by%20the%20Immunomonitoring%20Platform.%22%2C%22link%22%3A%22url%3Ahttps%253A%252F%252Ffci.health%252Fen%252Fresearch%252Fresearch-areas%252Ff2%252F%7C%7C%7C%22%2C%22color%22%3A%22gray%22%7D%2C%7B%22line1%22%3A%22P3%22%2C%22line2%22%3A%22Tumor%20Models%22%2C%22text%22%3A%22The%20aim%20of%20Technology%20Platform%203%20Tumor%20Models%20is%20to%20develop%20new%20tumor%20models%20that%20can%20be%20used%20to%20better%20predict%20the%20clinical%20success%20of%20a%20compound%20identified%20in%20basic%20research%20in%20patients.%20This%20platform%20represents%20the%20essential%20link%20for%20the%20transfer%20of%20new%20therapeutic%20strategies%20into%20the%20clinic.%20%22%2C%22link%22%3A%22url%3Ahttps%253A%252F%252Ffci.health%252Fen%252Fresearch%252Fresearch-areas%252Ff3%252F%7C%7C%7C%22%2C%22color%22%3A%22gray%22%7D%2C%7B%22line1%22%3A%22P4%22%2C%22line2%22%3A%22Drug%20Development%22%2C%22text%22%3A%22The%20goal%20of%20the%20Technology%20Platform%204%20is%20to%20develop%20new%20therapeutic%20approaches%20and%20to%20advance%20them%20to%20the%20development%20of%20new%20drugs.%20The%20extensive%20chemical%2C%20pharmaceutical%20and%20structural%20biology%20expertise%20at%20Goethe%20University%20in%20Frankfurt%20makes%20it%20possible%20to%20develop%20and%20optimize%20new%20drug%20candidates%20against%20validated%20target%20structures%3B%20innovative%20biologicals%20and%20cell%20therapeutics%20are%20developed%20at%20Georg-Speyer-Haus%20and%20the%20Paul-Ehrlich-Institut.%22%2C%22link%22%3A%22url%3Ahttps%253A%252F%252Ffci.health%252Fen%252Fresearch%252Fresearch-areas%252Ff4%252F%7C%7C%7C%22%2C%22color%22%3A%22gray%22%7D%2C%7B%22line1%22%3A%22P5%22%2C%22line2%22%3A%22Clinical%20Translation%20%26%20Biobank%22%2C%22text%22%3A%22The%20integration%20of%20clinical%20trials%20into%20the%20FCI%20is%20essential%20as%20an%20endpoint%20for%20drug%20development%20and%20a%20starting%20point%20for%20the%20investigation%20of%20response%20and%20resistance%20mechanisms.%20The%20goal%20is%20to%20initiate%20such%20studies%20in%20close%20collaboration%20with%20the%20University%20Center%20for%20Tumor%20Diseases%20(UCT).%20The%20UCT%20Frankfurt%20has%20continuously%20worked%20on%20the%20expansion%20of%20a%20comprehensive%20clinical%20research%20unit%2C%20which%20will%20be%20fully%20available%20to%20the%20FCI.%20This%20ensures%20the%20practical%20implementation%20of%20early%20translational%20studies%20at%20the%20FCI%20site.%22%2C%22link%22%3A%22url%3Ahttps%253A%252F%252Ffci.health%252Fen%252Fresearch%252Fresearch-areas%252Ff5%252F%7C%7C%7C%22%2C%22color%22%3A%22gray%22%7D%2C%7B%22line1%22%3A%22Discovery%20%26%20Development%22%2C%22text%22%3A%22The%20primary%20objective%20of%20this%20program%20is%20to%20address%20excellent%20hypotheses%20on%20basic%20biological%20mechanisms%20of%20tumorigenesis%2C%20progression%2C%20diagnosis%2C%20and%20therapy.%20%22%2C%22link%22%3A%22url%3Ahttps%253A%252F%252Ffci.health%252Fen%252Fresearch%252Fdiscovery-development%252F%7C%7C%7C%22%2C%22color%22%3A%22orange-light%22%7D%5D”][\/vc_column][\/vc_row][vc_row full_width=”stretch_row” dhsv_background_color=”bg_brand-primary”][vc_column][dhsv_vc_anker type=”point” title=”Events” id=”events”][dhsv_vc_events][\/vc_column][\/vc_row][vc_row][vc_column][vc_empty_space][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]<\/p>\n

Past lectures (archive) can be found here<\/span><\/a><\/h4>\n

[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_empty_space][\/vc_column][\/vc_row][vc_row disable_element=”yes”][vc_column][dhsv_vc_twitter][\/vc_column][\/vc_row][vc_row full_width=”stretch_row” dhsv_background_color=”bg_gray” dhsv_bgposition=”vc-bgposition-bottom-left” css=”.vc_custom_1537259528739{background-image: url(https:\/\/fci.health\/wp-content\/uploads\/FCI-Pressemeldung-Grau-Invert.jpeg?id=718) !important;}” el_class=”bgimage001″][vc_column offset=”vc_col-md-6″][\/vc_column][vc_column offset=”vc_col-md-6″][dhsv_vc_anker type=”point” title=”Presse” id=”presse”][dhsv_vc_pressemeldungen][dhsv_vc_anker type=”end”][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

[vc_row full_width=”stretch_row_content_no_spaces” dhsv_overflow=”vc-overflow-visible”][vc_column][dhsv_vc_header type=”video” video=”472″ video_mobile=”499″ texttop=”Einzigartige Umgebung” textbottom=”Wissensvermittlung an Patienten” elements=”%5B%7B%22texttop%22%3A%22Unique%20Environment%22%2C%22textbottom%22%3A%22Interdisciplinary%22%7D%2C%7B%22texttop%22%3A%22Molecular%20Mechanisms%22%2C%22textbottom%22%3A%22Precision%20Oncology%22%7D%2C%7B%22texttop%22%3A%22Translation%20and%20Reverse%20Translation%22%2C%22textbottom%22%3A%22Innovation%22%7D%2C%7B%22texttop%22%3A%22Exceptional%20Career%20Opportunities%22%2C%22textbottom%22%3A%22Spirit%20of%20collaboration%22%7D%2C%7B%22texttop%22%3A%22Team%20Culture%22%2C%22textbottom%22%3A%22Interdisciplinary%20Education%22%7D%2C%7B%22texttop%22%3A%22Shared%20Cutting%20Edge%20Resources%22%2C%22textbottom%22%3A%22Bottom-up%20Ideas%22%7D%5D”][\/vc_column][\/vc_row][vc_row dhsv_margin_top=”vc-margin-top-medium” dhsv_margin_bottom=”vc-margin-bottom-medium”][vc_column][dhsv_vc_anker type=”nav”][dhsv_vc_forschungsbereiche headtitle=”Research at FCI” elements=”%5B%7B%22line1%22%3A%22Clinical%20Translation%20Programs%22%2C%22line2%22%3A%22Strategic%20Core%20of%20FCI%22%2C%22text%22%3A%22Multidisciplinary%20teams%20consisting%20of%20clinicians%2C%20tumor%20biologists%2C%20biochemists%2C%20chemists%20and%20bioinformaticians%20work%20together%20in%20these%20interdisciplinary%20research%20projects.%20The%20teams%20rely%20on%20the%20technology%20platforms%20provided%20by%20the%20five%20research%20areas.%20%22%2C%22link%22%3A%22url%3Ahttps%253A%252F%252Ffci.health%252Fen%252Fresearch%252Fclinical-translation-programs%252F%7C%7C%7C%22%2C%22color%22%3A%22blue%22%7D%2C%7B%22line1%22%3A%22P1%22%2C%22line2%22%3A%22Proteomics%20%26%20Functional%20Genomics%22%2C%22text%22%3A%22The%20goal%20of%20Technology%20Platform%201%20is%20to%20find%20individual%20parameters%20that%20can%20improve%20the%20diagnosis%20of%20tumors%20or%20better%20predict%20the%20response%20to%20therapy.%20For%20example%2C%20the%20composition%20of%20all%20proteins%20in%20a%20cell%20can%20be%20qualitatively%20and%20quantitatively%20analyzed%20by%20means%20of%20mass%20spectrometry.%20The%20measured%20profile%20(%E2%80%9Cproteome%E2%80%9D)%20contains%20unique%20information%20%E2%80%93%20similar%20to%20a%20fingerprint%20%E2%80%93%20and%20by%20comparing%20tumor%20cells%20with%20healthy%20cells%20of%20the%20same%20patient%2C%20new%20prognostic%20and%20diagnostic%20criteria%20can%20be%20identified.%22%2C%22link%22%3A%22url%3Ahttps%253A%252F%252Ffci.health%252Fen%252Fresearch%252Fresearch-areas%252Ff1%252F%7C%7C%7C%22%2C%22color%22%3A%22gray%22%7D%2C%7B%22line1%22%3A%22P2%22%2C%22line2%22%3A%22Immuno-Oncology%22%2C%22text%22%3A%22Technology%20platform%202%20Immuno-Oncology%20uses%20the%20innovative%20cell%20type-specific%20gene%20transfer%20technologies%20available%20at%20FCI%20to%20develop%20new%20immunotherapeutic%20concepts.%20These%20include%20the%20genetic%20modification%20of%20T%20lymphocytes%20or%20natural%20killer%20cells%20(NKs)%20with%20chimeric%20antigen%20receptors%20(CARs)%20as%20well%20as%20the%20precise%20transfer%20of%20immunomodulatory%20agents%20into%20tumor%20tissue.%5CnThis%20is%20complemented%20by%20the%20Immunomonitoring%20Platform.%22%2C%22link%22%3A%22url%3Ahttps%253A%252F%252Ffci.health%252Fen%252Fresearch%252Fresearch-areas%252Ff2%252F%7C%7C%7C%22%2C%22color%22%3A%22gray%22%7D%2C%7B%22line1%22%3A%22P3%22%2C%22line2%22%3A%22Tumor%20Models%22%2C%22text%22%3A%22The%20aim%20of%20Technology%20Platform%203%20Tumor%20Models%20is%20to%20develop%20new%20tumor%20models%20that%20can%20be%20used%20to%20better%20predict%20the%20clinical%20success%20of%20a%20compound%20identified%20in%20basic%20research%20in%20patients.%20This%20platform%20represents%20the%20essential%20link%20for%20the%20transfer%20of%20new%20therapeutic%20strategies%20into%20the%20clinic.%20%22%2C%22link%22%3A%22url%3Ahttps%253A%252F%252Ffci.health%252Fen%252Fresearch%252Fresearch-areas%252Ff3%252F%7C%7C%7C%22%2C%22color%22%3A%22gray%22%7D%2C%7B%22line1%22%3A%22P4%22%2C%22line2%22%3A%22Drug%20Development%22%2C%22text%22%3A%22The%20goal%20of%20the%20Technology%20Platform%204%20is%20to%20develop%20new%20therapeutic%20approaches%20and%20to%20advance%20them%20to%20the%20development%20of%20new%20drugs.%20The%20extensive%20chemical%2C%20pharmaceutical%20and%20structural%20biology%20expertise%20at%20Goethe%20University%20in%20Frankfurt%20makes%20it%20possible%20to%20develop%20and%20optimize%20new%20drug%20candidates%20against%20validated%20target%20structures%3B%20innovative%20biologicals%20and%20cell%20therapeutics%20are%20developed%20at%20Georg-Speyer-Haus%20and%20the%20Paul-Ehrlich-Institut.%22%2C%22link%22%3A%22url%3Ahttps%253A%252F%252Ffci.health%252Fen%252Fresearch%252Fresearch-areas%252Ff4%252F%7C%7C%7C%22%2C%22color%22%3A%22gray%22%7D%2C%7B%22line1%22%3A%22P5%22%2C%22line2%22%3A%22Clinical%20Translation%20%26%20Biobank%22%2C%22text%22%3A%22The%20integration%20of%20clinical%20trials%20into%20the%20FCI%20is%20essential%20as%20an%20endpoint%20for%20drug%20development%20and%20a%20starting%20point%20for%20the%20investigation%20of%20response%20and%20resistance%20mechanisms.%20The%20goal%20is%20to%20initiate%20such%20studies%20in%20close%20collaboration%20with%20the%20University%20Center%20for%20Tumor%20Diseases%20(UCT).%20The%20UCT%20Frankfurt%20has%20continuously%20worked%20on%20the%20expansion%20of%20a%20comprehensive%20clinical%20research%20unit%2C%20which%20will%20be%20fully%20available%20to%20the%20FCI.%20This%20ensures%20the%20practical%20implementation%20of%20early%20translational%20studies%20at%20the%20FCI%20site.%22%2C%22link%22%3A%22url%3Ahttps%253A%252F%252Ffci.health%252Fen%252Fresearch%252Fresearch-areas%252Ff5%252F%7C%7C%7C%22%2C%22color%22%3A%22gray%22%7D%2C%7B%22line1%22%3A%22Discovery%20%26%20Development%22%2C%22text%22%3A%22The%20primary%20objective%20of%20this%20program%20is%20to%20address%20excellent%20hypotheses%20on%20basic%20biological%20mechanisms%20of%20tumorigenesis%2C%20progression%2C%20diagnosis%2C%20and%20therapy.%20%22%2C%22link%22%3A%22url%3Ahttps%253A%252F%252Ffci.health%252Fen%252Fresearch%252Fdiscovery-development%252F%7C%7C%7C%22%2C%22color%22%3A%22orange-light%22%7D%5D”][\/vc_column][\/vc_row][vc_row full_width=”stretch_row” dhsv_background_color=”bg_brand-primary”][vc_column][dhsv_vc_anker type=”point” title=”Events” id=”events”][dhsv_vc_events][\/vc_column][\/vc_row][vc_row][vc_column][vc_empty_space][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text] Past lectures (archive) can be found here [\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_empty_space][\/vc_column][\/vc_row][vc_row disable_element=”yes”][vc_column][dhsv_vc_twitter][\/vc_column][\/vc_row][vc_row full_width=”stretch_row” dhsv_background_color=”bg_gray” dhsv_bgposition=”vc-bgposition-bottom-left” css=”.vc_custom_1537259528739{background-image: url(https:\/\/fci.health\/wp-content\/uploads\/FCI-Pressemeldung-Grau-Invert.jpeg?id=718) !important;}” el_class=”bgimage001″][vc_column offset=”vc_col-md-6″][\/vc_column][vc_column offset=”vc_col-md-6″][dhsv_vc_anker type=”point” title=”Presse” id=”presse”][dhsv_vc_pressemeldungen][dhsv_vc_anker type=”end”][\/vc_column][\/vc_row]<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":23,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-579","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"\nHomepage • Frankfurt Cancer Institute<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fci.health\/en\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Homepage • Frankfurt Cancer Institute\" \/>\n<meta property=\"og:description\" content=\"[vc_row full_width=”stretch_row_content_no_spaces” dhsv_overflow=”vc-overflow-visible”][vc_column][dhsv_vc_header type=”video” video=”472″ video_mobile=”499″ texttop=”Einzigartige Umgebung” textbottom=”Wissensvermittlung an Patienten” elements=”%5B%7B%22texttop%22%3A%22Unique%20Environment%22%2C%22textbottom%22%3A%22Interdisciplinary%22%7D%2C%7B%22texttop%22%3A%22Molecular%20Mechanisms%22%2C%22textbottom%22%3A%22Precision%20Oncology%22%7D%2C%7B%22texttop%22%3A%22Translation%20and%20Reverse%20Translation%22%2C%22textbottom%22%3A%22Innovation%22%7D%2C%7B%22texttop%22%3A%22Exceptional%20Career%20Opportunities%22%2C%22textbottom%22%3A%22Spirit%20of%20collaboration%22%7D%2C%7B%22texttop%22%3A%22Team%20Culture%22%2C%22textbottom%22%3A%22Interdisciplinary%20Education%22%7D%2C%7B%22texttop%22%3A%22Shared%20Cutting%20Edge%20Resources%22%2C%22textbottom%22%3A%22Bottom-up%20Ideas%22%7D%5D”][\/vc_column][\/vc_row][vc_row dhsv_margin_top=”vc-margin-top-medium” dhsv_margin_bottom=”vc-margin-bottom-medium”][vc_column][dhsv_vc_anker type=”nav”][dhsv_vc_forschungsbereiche headtitle=”Research at FCI” elements=”%5B%7B%22line1%22%3A%22Clinical%20Translation%20Programs%22%2C%22line2%22%3A%22Strategic%20Core%20of%20FCI%22%2C%22text%22%3A%22Multidisciplinary%20teams%20consisting%20of%20clinicians%2C%20tumor%20biologists%2C%20biochemists%2C%20chemists%20and%20bioinformaticians%20work%20together%20in%20these%20interdisciplinary%20research%20projects.%20The%20teams%20rely%20on%20the%20technology%20platforms%20provided%20by%20the%20five%20research%20areas.%20%22%2C%22link%22%3A%22url%3Ahttps%253A%252F%252Ffci.health%252Fen%252Fresearch%252Fclinical-translation-programs%252F%7C%7C%7C%22%2C%22color%22%3A%22blue%22%7D%2C%7B%22line1%22%3A%22P1%22%2C%22line2%22%3A%22Proteomics%20%26%20Functional%20Genomics%22%2C%22text%22%3A%22The%20goal%20of%20Technology%20Platform%201%20is%20to%20find%20individual%20parameters%20that%20can%20improve%20the%20diagnosis%20of%20tumors%20or%20better%20predict%20the%20response%20to%20therapy.%20For%20example%2C%20the%20composition%20of%20all%20proteins%20in%20a%20cell%20can%20be%20qualitatively%20and%20quantitatively%20analyzed%20by%20means%20of%20mass%20spectrometry.%20The%20measured%20profile%20(%E2%80%9Cproteome%E2%80%9D)%20contains%20unique%20information%20%E2%80%93%20similar%20to%20a%20fingerprint%20%E2%80%93%20and%20by%20comparing%20tumor%20cells%20with%20healthy%20cells%20of%20the%20same%20patient%2C%20new%20prognostic%20and%20diagnostic%20criteria%20can%20be%20identified.%22%2C%22link%22%3A%22url%3Ahttps%253A%252F%252Ffci.health%252Fen%252Fresearch%252Fresearch-areas%252Ff1%252F%7C%7C%7C%22%2C%22color%22%3A%22gray%22%7D%2C%7B%22line1%22%3A%22P2%22%2C%22line2%22%3A%22Immuno-Oncology%22%2C%22text%22%3A%22Technology%20platform%202%20Immuno-Oncology%20uses%20the%20innovative%20cell%20type-specific%20gene%20transfer%20technologies%20available%20at%20FCI%20to%20develop%20new%20immunotherapeutic%20concepts.%20These%20include%20the%20genetic%20modification%20of%20T%20lymphocytes%20or%20natural%20killer%20cells%20(NKs)%20with%20chimeric%20antigen%20receptors%20(CARs)%20as%20well%20as%20the%20precise%20transfer%20of%20immunomodulatory%20agents%20into%20tumor%20tissue.%5CnThis%20is%20complemented%20by%20the%20Immunomonitoring%20Platform.%22%2C%22link%22%3A%22url%3Ahttps%253A%252F%252Ffci.health%252Fen%252Fresearch%252Fresearch-areas%252Ff2%252F%7C%7C%7C%22%2C%22color%22%3A%22gray%22%7D%2C%7B%22line1%22%3A%22P3%22%2C%22line2%22%3A%22Tumor%20Models%22%2C%22text%22%3A%22The%20aim%20of%20Technology%20Platform%203%20Tumor%20Models%20is%20to%20develop%20new%20tumor%20models%20that%20can%20be%20used%20to%20better%20predict%20the%20clinical%20success%20of%20a%20compound%20identified%20in%20basic%20research%20in%20patients.%20This%20platform%20represents%20the%20essential%20link%20for%20the%20transfer%20of%20new%20therapeutic%20strategies%20into%20the%20clinic.%20%22%2C%22link%22%3A%22url%3Ahttps%253A%252F%252Ffci.health%252Fen%252Fresearch%252Fresearch-areas%252Ff3%252F%7C%7C%7C%22%2C%22color%22%3A%22gray%22%7D%2C%7B%22line1%22%3A%22P4%22%2C%22line2%22%3A%22Drug%20Development%22%2C%22text%22%3A%22The%20goal%20of%20the%20Technology%20Platform%204%20is%20to%20develop%20new%20therapeutic%20approaches%20and%20to%20advance%20them%20to%20the%20development%20of%20new%20drugs.%20The%20extensive%20chemical%2C%20pharmaceutical%20and%20structural%20biology%20expertise%20at%20Goethe%20University%20in%20Frankfurt%20makes%20it%20possible%20to%20develop%20and%20optimize%20new%20drug%20candidates%20against%20validated%20target%20structures%3B%20innovative%20biologicals%20and%20cell%20therapeutics%20are%20developed%20at%20Georg-Speyer-Haus%20and%20the%20Paul-Ehrlich-Institut.%22%2C%22link%22%3A%22url%3Ahttps%253A%252F%252Ffci.health%252Fen%252Fresearch%252Fresearch-areas%252Ff4%252F%7C%7C%7C%22%2C%22color%22%3A%22gray%22%7D%2C%7B%22line1%22%3A%22P5%22%2C%22line2%22%3A%22Clinical%20Translation%20%26%20Biobank%22%2C%22text%22%3A%22The%20integration%20of%20clinical%20trials%20into%20the%20FCI%20is%20essential%20as%20an%20endpoint%20for%20drug%20development%20and%20a%20starting%20point%20for%20the%20investigation%20of%20response%20and%20resistance%20mechanisms.%20The%20goal%20is%20to%20initiate%20such%20studies%20in%20close%20collaboration%20with%20the%20University%20Center%20for%20Tumor%20Diseases%20(UCT).%20The%20UCT%20Frankfurt%20has%20continuously%20worked%20on%20the%20expansion%20of%20a%20comprehensive%20clinical%20research%20unit%2C%20which%20will%20be%20fully%20available%20to%20the%20FCI.%20This%20ensures%20the%20practical%20implementation%20of%20early%20translational%20studies%20at%20the%20FCI%20site.%22%2C%22link%22%3A%22url%3Ahttps%253A%252F%252Ffci.health%252Fen%252Fresearch%252Fresearch-areas%252Ff5%252F%7C%7C%7C%22%2C%22color%22%3A%22gray%22%7D%2C%7B%22line1%22%3A%22Discovery%20%26%20Development%22%2C%22text%22%3A%22The%20primary%20objective%20of%20this%20program%20is%20to%20address%20excellent%20hypotheses%20on%20basic%20biological%20mechanisms%20of%20tumorigenesis%2C%20progression%2C%20diagnosis%2C%20and%20therapy.%20%22%2C%22link%22%3A%22url%3Ahttps%253A%252F%252Ffci.health%252Fen%252Fresearch%252Fdiscovery-development%252F%7C%7C%7C%22%2C%22color%22%3A%22orange-light%22%7D%5D”][\/vc_column][\/vc_row][vc_row full_width=”stretch_row” dhsv_background_color=”bg_brand-primary”][vc_column][dhsv_vc_anker type=”point” title=”Events” id=”events”][dhsv_vc_events][\/vc_column][\/vc_row][vc_row][vc_column][vc_empty_space][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text] Past lectures (archive) can be found here [\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_empty_space][\/vc_column][\/vc_row][vc_row disable_element=”yes”][vc_column][dhsv_vc_twitter][\/vc_column][\/vc_row][vc_row full_width=”stretch_row” dhsv_background_color=”bg_gray” dhsv_bgposition=”vc-bgposition-bottom-left” css=”.vc_custom_1537259528739{background-image: url(https:\/\/fci.health\/wp-content\/uploads\/FCI-Pressemeldung-Grau-Invert.jpeg?id=718) !important;}” el_class=”bgimage001″][vc_column offset=”vc_col-md-6″][\/vc_column][vc_column offset=”vc_col-md-6″][dhsv_vc_anker type=”point” title=”Presse” id=”presse”][dhsv_vc_pressemeldungen][dhsv_vc_anker type=”end”][\/vc_column][\/vc_row]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fci.health\/en\/\" \/>\n<meta property=\"og:site_name\" content=\"Frankfurt Cancer Institute\" \/>\n<meta property=\"article:modified_time\" content=\"2023-12-04T08:44:39+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fci.health\\\/en\\\/\",\"url\":\"https:\\\/\\\/fci.health\\\/en\\\/\",\"name\":\"Homepage • Frankfurt Cancer Institute\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fci.health\\\/#website\"},\"datePublished\":\"2018-07-19T06:24:26+00:00\",\"dateModified\":\"2023-12-04T08:44:39+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fci.health\\\/en\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fci.health\\\/en\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fci.health\\\/en\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/fci.health\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Homepage\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fci.health\\\/#website\",\"url\":\"https:\\\/\\\/fci.health\\\/\",\"name\":\"Frankfurt Cancer Institute\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fci.health\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Homepage • Frankfurt Cancer Institute","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fci.health\/en\/","og_locale":"en_US","og_type":"article","og_title":"Homepage • Frankfurt Cancer Institute","og_description":"[vc_row full_width=”stretch_row_content_no_spaces” dhsv_overflow=”vc-overflow-visible”][vc_column][dhsv_vc_header type=”video” video=”472″ video_mobile=”499″ texttop=”Einzigartige Umgebung” textbottom=”Wissensvermittlung an Patienten” elements=”%5B%7B%22texttop%22%3A%22Unique%20Environment%22%2C%22textbottom%22%3A%22Interdisciplinary%22%7D%2C%7B%22texttop%22%3A%22Molecular%20Mechanisms%22%2C%22textbottom%22%3A%22Precision%20Oncology%22%7D%2C%7B%22texttop%22%3A%22Translation%20and%20Reverse%20Translation%22%2C%22textbottom%22%3A%22Innovation%22%7D%2C%7B%22texttop%22%3A%22Exceptional%20Career%20Opportunities%22%2C%22textbottom%22%3A%22Spirit%20of%20collaboration%22%7D%2C%7B%22texttop%22%3A%22Team%20Culture%22%2C%22textbottom%22%3A%22Interdisciplinary%20Education%22%7D%2C%7B%22texttop%22%3A%22Shared%20Cutting%20Edge%20Resources%22%2C%22textbottom%22%3A%22Bottom-up%20Ideas%22%7D%5D”][\/vc_column][\/vc_row][vc_row dhsv_margin_top=”vc-margin-top-medium” dhsv_margin_bottom=”vc-margin-bottom-medium”][vc_column][dhsv_vc_anker type=”nav”][dhsv_vc_forschungsbereiche headtitle=”Research at FCI” elements=”%5B%7B%22line1%22%3A%22Clinical%20Translation%20Programs%22%2C%22line2%22%3A%22Strategic%20Core%20of%20FCI%22%2C%22text%22%3A%22Multidisciplinary%20teams%20consisting%20of%20clinicians%2C%20tumor%20biologists%2C%20biochemists%2C%20chemists%20and%20bioinformaticians%20work%20together%20in%20these%20interdisciplinary%20research%20projects.%20The%20teams%20rely%20on%20the%20technology%20platforms%20provided%20by%20the%20five%20research%20areas.%20%22%2C%22link%22%3A%22url%3Ahttps%253A%252F%252Ffci.health%252Fen%252Fresearch%252Fclinical-translation-programs%252F%7C%7C%7C%22%2C%22color%22%3A%22blue%22%7D%2C%7B%22line1%22%3A%22P1%22%2C%22line2%22%3A%22Proteomics%20%26%20Functional%20Genomics%22%2C%22text%22%3A%22The%20goal%20of%20Technology%20Platform%201%20is%20to%20find%20individual%20parameters%20that%20can%20improve%20the%20diagnosis%20of%20tumors%20or%20better%20predict%20the%20response%20to%20therapy.%20For%20example%2C%20the%20composition%20of%20all%20proteins%20in%20a%20cell%20can%20be%20qualitatively%20and%20quantitatively%20analyzed%20by%20means%20of%20mass%20spectrometry.%20The%20measured%20profile%20(%E2%80%9Cproteome%E2%80%9D)%20contains%20unique%20information%20%E2%80%93%20similar%20to%20a%20fingerprint%20%E2%80%93%20and%20by%20comparing%20tumor%20cells%20with%20healthy%20cells%20of%20the%20same%20patient%2C%20new%20prognostic%20and%20diagnostic%20criteria%20can%20be%20identified.%22%2C%22link%22%3A%22url%3Ahttps%253A%252F%252Ffci.health%252Fen%252Fresearch%252Fresearch-areas%252Ff1%252F%7C%7C%7C%22%2C%22color%22%3A%22gray%22%7D%2C%7B%22line1%22%3A%22P2%22%2C%22line2%22%3A%22Immuno-Oncology%22%2C%22text%22%3A%22Technology%20platform%202%20Immuno-Oncology%20uses%20the%20innovative%20cell%20type-specific%20gene%20transfer%20technologies%20available%20at%20FCI%20to%20develop%20new%20immunotherapeutic%20concepts.%20These%20include%20the%20genetic%20modification%20of%20T%20lymphocytes%20or%20natural%20killer%20cells%20(NKs)%20with%20chimeric%20antigen%20receptors%20(CARs)%20as%20well%20as%20the%20precise%20transfer%20of%20immunomodulatory%20agents%20into%20tumor%20tissue.%5CnThis%20is%20complemented%20by%20the%20Immunomonitoring%20Platform.%22%2C%22link%22%3A%22url%3Ahttps%253A%252F%252Ffci.health%252Fen%252Fresearch%252Fresearch-areas%252Ff2%252F%7C%7C%7C%22%2C%22color%22%3A%22gray%22%7D%2C%7B%22line1%22%3A%22P3%22%2C%22line2%22%3A%22Tumor%20Models%22%2C%22text%22%3A%22The%20aim%20of%20Technology%20Platform%203%20Tumor%20Models%20is%20to%20develop%20new%20tumor%20models%20that%20can%20be%20used%20to%20better%20predict%20the%20clinical%20success%20of%20a%20compound%20identified%20in%20basic%20research%20in%20patients.%20This%20platform%20represents%20the%20essential%20link%20for%20the%20transfer%20of%20new%20therapeutic%20strategies%20into%20the%20clinic.%20%22%2C%22link%22%3A%22url%3Ahttps%253A%252F%252Ffci.health%252Fen%252Fresearch%252Fresearch-areas%252Ff3%252F%7C%7C%7C%22%2C%22color%22%3A%22gray%22%7D%2C%7B%22line1%22%3A%22P4%22%2C%22line2%22%3A%22Drug%20Development%22%2C%22text%22%3A%22The%20goal%20of%20the%20Technology%20Platform%204%20is%20to%20develop%20new%20therapeutic%20approaches%20and%20to%20advance%20them%20to%20the%20development%20of%20new%20drugs.%20The%20extensive%20chemical%2C%20pharmaceutical%20and%20structural%20biology%20expertise%20at%20Goethe%20University%20in%20Frankfurt%20makes%20it%20possible%20to%20develop%20and%20optimize%20new%20drug%20candidates%20against%20validated%20target%20structures%3B%20innovative%20biologicals%20and%20cell%20therapeutics%20are%20developed%20at%20Georg-Speyer-Haus%20and%20the%20Paul-Ehrlich-Institut.%22%2C%22link%22%3A%22url%3Ahttps%253A%252F%252Ffci.health%252Fen%252Fresearch%252Fresearch-areas%252Ff4%252F%7C%7C%7C%22%2C%22color%22%3A%22gray%22%7D%2C%7B%22line1%22%3A%22P5%22%2C%22line2%22%3A%22Clinical%20Translation%20%26%20Biobank%22%2C%22text%22%3A%22The%20integration%20of%20clinical%20trials%20into%20the%20FCI%20is%20essential%20as%20an%20endpoint%20for%20drug%20development%20and%20a%20starting%20point%20for%20the%20investigation%20of%20response%20and%20resistance%20mechanisms.%20The%20goal%20is%20to%20initiate%20such%20studies%20in%20close%20collaboration%20with%20the%20University%20Center%20for%20Tumor%20Diseases%20(UCT).%20The%20UCT%20Frankfurt%20has%20continuously%20worked%20on%20the%20expansion%20of%20a%20comprehensive%20clinical%20research%20unit%2C%20which%20will%20be%20fully%20available%20to%20the%20FCI.%20This%20ensures%20the%20practical%20implementation%20of%20early%20translational%20studies%20at%20the%20FCI%20site.%22%2C%22link%22%3A%22url%3Ahttps%253A%252F%252Ffci.health%252Fen%252Fresearch%252Fresearch-areas%252Ff5%252F%7C%7C%7C%22%2C%22color%22%3A%22gray%22%7D%2C%7B%22line1%22%3A%22Discovery%20%26%20Development%22%2C%22text%22%3A%22The%20primary%20objective%20of%20this%20program%20is%20to%20address%20excellent%20hypotheses%20on%20basic%20biological%20mechanisms%20of%20tumorigenesis%2C%20progression%2C%20diagnosis%2C%20and%20therapy.%20%22%2C%22link%22%3A%22url%3Ahttps%253A%252F%252Ffci.health%252Fen%252Fresearch%252Fdiscovery-development%252F%7C%7C%7C%22%2C%22color%22%3A%22orange-light%22%7D%5D”][\/vc_column][\/vc_row][vc_row full_width=”stretch_row” dhsv_background_color=”bg_brand-primary”][vc_column][dhsv_vc_anker type=”point” title=”Events” id=”events”][dhsv_vc_events][\/vc_column][\/vc_row][vc_row][vc_column][vc_empty_space][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text] Past lectures (archive) can be found here [\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_empty_space][\/vc_column][\/vc_row][vc_row disable_element=”yes”][vc_column][dhsv_vc_twitter][\/vc_column][\/vc_row][vc_row full_width=”stretch_row” dhsv_background_color=”bg_gray” dhsv_bgposition=”vc-bgposition-bottom-left” css=”.vc_custom_1537259528739{background-image: url(https:\/\/fci.health\/wp-content\/uploads\/FCI-Pressemeldung-Grau-Invert.jpeg?id=718) !important;}” el_class=”bgimage001″][vc_column offset=”vc_col-md-6″][\/vc_column][vc_column offset=”vc_col-md-6″][dhsv_vc_anker type=”point” title=”Presse” id=”presse”][dhsv_vc_pressemeldungen][dhsv_vc_anker type=”end”][\/vc_column][\/vc_row]","og_url":"https:\/\/fci.health\/en\/","og_site_name":"Frankfurt Cancer Institute","article_modified_time":"2023-12-04T08:44:39+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/fci.health\/en\/","url":"https:\/\/fci.health\/en\/","name":"Homepage • Frankfurt Cancer Institute","isPartOf":{"@id":"https:\/\/fci.health\/#website"},"datePublished":"2018-07-19T06:24:26+00:00","dateModified":"2023-12-04T08:44:39+00:00","breadcrumb":{"@id":"https:\/\/fci.health\/en\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fci.health\/en\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/fci.health\/en\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/fci.health\/en\/"},{"@type":"ListItem","position":2,"name":"Homepage"}]},{"@type":"WebSite","@id":"https:\/\/fci.health\/#website","url":"https:\/\/fci.health\/","name":"Frankfurt Cancer Institute","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fci.health\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/fci.health\/en\/wp-json\/wp\/v2\/pages\/579","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fci.health\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/fci.health\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/fci.health\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/fci.health\/en\/wp-json\/wp\/v2\/comments?post=579"}],"version-history":[{"count":5,"href":"https:\/\/fci.health\/en\/wp-json\/wp\/v2\/pages\/579\/revisions"}],"predecessor-version":[{"id":3724,"href":"https:\/\/fci.health\/en\/wp-json\/wp\/v2\/pages\/579\/revisions\/3724"}],"wp:attachment":[{"href":"https:\/\/fci.health\/en\/wp-json\/wp\/v2\/media?parent=579"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}